Hepatic protein tyrosine phosphatase Shp2 disruption mitigates the adverse effects of ethanol in the liver by modulating oxidative stress and ERK signaling
- Life Sci. 2024 Jan 20:122451. doi: 10.1016/j.lfs.2024.122451.
- 1. Department of Nutrition, University of California Davis, One Shields Ave, Davis, CA 95616, USA. Electronic address: [email protected].
- 2. Department of Nutrition, University of California Davis, One Shields Ave, Davis, CA 95616, USA.
- 3. Department of Inflammation and Immunity, Cleveland Clinic Foundation, Cleveland, OH 44195, USA.
- 4. Department of Nutrition, University of California Davis, One Shields Ave, Davis, CA 95616, USA; Comprehensive Cancer Center, University of California Davis, Sacramento, CA 95817, USA; Division of Endocrinology, Diabetes, and Metabolism, Department of Internal Medicine, University of California Davis, Sacramento, CA 95817, USA. Electronic address: [email protected].
Aims: Chronic excessive alcohol intake is a significant cause of alcohol-associated liver disease (ALD), a leading contributor to liver-related morbidity and mortality. The Src homology Phosphatase 2 (Shp2; encoded by Ptpn11) is a widely expressed protein tyrosine Phosphatase that modulates hepatic functions, but its role in ALD is mostly uncharted.
Main methods: Herein, we explore the effects of liver-specific SHP2 genetic disruption using the established chronic-plus-binge mouse model of ALD.
Key findings: We report that the hepatic SHP2 disruption had beneficial effects and partially ameliorated ethanol-induced injury, inflammation, and steatosis in the liver. Consistently, SHP2 deficiency was associated with decreased ethanol-evoked activation of extracellular signal-regulated kinase (ERK) and oxidative stress in the liver. Moreover, primary hepatocytes with SHP2 deficiency exhibited similar outcomes to those observed upon SHP2 disruption in vivo, including diminished ethanol-induced ERK activation, inflammation, and oxidative stress. Furthermore, pharmacological inhibition of ERK in primary hepatocytes mimicked the effects of SHP2 deficiency and attenuated oxidative stress caused by ethanol.
Significance: Collectively, these findings highlight SHP2 as a modulator of hepatic oxidative stress upon ethanol challenge and suggest the evaluation of this Phosphatase as a potential therapeutic target for ALD.